First Republic Investment Management, Inc. Global Blood Therapeutics, Inc. Transaction History

First Republic Investment Management, Inc.

$34.7 Billion
Q3 2023

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 03, 2022	SELL	$32.4 - $68.18 $92,242 - $194,108	-2,847 Reduced 15.58%	15,431 $1.05 Million
Q2 2022 Aug 16, 2022	SELL	$22.3 - $37.39 $32,558 - $54,589	-1,460 Reduced 7.4%	18,278 $584,000
Q1 2022 May 16, 2022	SELL	$25.68 - $35.59 $58,781 - $81,465	-2,289 Reduced 10.39%	19,738 $684,000
Q4 2021 Feb 09, 2022	SELL	$24.9 - $40.26 $29,780 - $48,150	-1,196 Reduced 5.15%	22,027 $645,000
Q3 2021 Nov 12, 2021	SELL	$25.48 - $37.34 $12,841 - $18,819	-504 Reduced 2.12%	23,223 $592,000
Q2 2021 Aug 16, 2021	SELL	$32.46 - $43.42 $440,612 - $589,383	-13,574 Reduced 36.39%	23,727 $831,000
Q1 2021 May 14, 2021	SELL	$38.94 - $50.85 $109,187 - $142,583	-2,804 Reduced 6.99%	37,301 $1.52 Million
Q4 2020 Feb 16, 2021	BUY	$37.65 - $63.77 $19,954 - $33,798	530 Added 1.34%	40,105 $1.74 Million
Q3 2020 Nov 12, 2020	BUY	$52.76 - $74.49 $983,446 - $1.39 Million	18,640 Added 89.04%	39,575 $2.18 Million
Q2 2020 Aug 13, 2020	BUY	$48.73 - $81.82 $20,661 - $34,691	424 Added 2.07%	20,935 $1.32 Million
Q1 2020 May 13, 2020	BUY	$41.72 - $87.2 $425,043 - $888,393	10,188 Added 98.69%	20,511 $1.05 Million
Q4 2019 Feb 14, 2020	BUY	$45.7 - $81.86 $5,803 - $10,396	127 Added 1.25%	10,323 $821,000
Q3 2019 Nov 08, 2019	BUY	$45.35 - $57.91 $138,000 - $176,220	3,043 Added 42.54%	10,196 $495,000
Q2 2019 Aug 07, 2019	SELL	$52.6 - $63.29 $94,364 - $113,542	-1,794 Reduced 20.05%	7,153 $376,000
Q1 2019 Apr 30, 2019	BUY	$39.99 - $53.48 $34,151 - $45,671	854 Added 10.55%	8,947 $474,000
Q4 2018 Feb 12, 2019	BUY	$31.54 - $46.67 $255,253 - $377,700	8,093 New	8,093 $332,000
Q3 2018 Nov 13, 2018	SELL	$38.0 - $51.1 $272,270 - $366,131	-7,165 Closed	0 $0
Q1 2018 May 10, 2018	SELL	$39.6 - $65.9 $24,512 - $40,792	-619 Reduced 7.95%	7,165 $346,000
Q4 2017 Feb 09, 2018	BUY	$29.7 - $45.7 $4,841 - $7,449	163 Added 2.14%	7,784 $306,000
Q3 2017 Nov 14, 2017	BUY	$25.1 - $31.05 $191,287 - $236,632	7,621	7,621 $237,000

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.

Account